Goodsurance

Policy & oversight

CMS Says It Stopped 1.6 Billion Dollars in Potentially Fraudulent Medicare Lab Payments Using Artificial Intelligence

The agency credits machine learning and advanced analytics for faster detection of suspicious laboratory billing, with results spanning revocations, payment suspensions, and recovered overpayments.

By the Goodsurance editorial teamSeptember 1, 2026

The Centers for Medicare and Medicaid Services announced that enforcement actions have halted more than 1.6 billion dollars in potentially improper Medicare laboratory payments since the start of the current administration. The agency attributes the results to advanced analytics, including artificial intelligence and machine-learning models, that scan Medicare fee-for-service claims for unusual billing patterns in near real time.

CMS broke down the total across four categories: 732 million dollars in savings and recovered amounts from revoking 157 fraudulent lab providers from the Medicare program; more than 500 million dollars in payments halted through 185 active payment suspensions; 276 million dollars recouped from 442 identified overpayments; and 127 million dollars in payments blocked because of 85 law enforcement referrals.

1.6 billion dollars in Medicare lab fraud stopped. CMS says AI flagged suspicious billing faster than traditional review methods.

In one example cited by CMS, analysts detected suspicious billing from a Texas-based laboratory within weeks of the lab beginning operations. A payment suspension blocked more than 150 thousand dollars in additional suspect payments before the provider was revoked from Medicare.

For Medicare beneficiaries, improper laboratory billing raises overall program costs over time, which can put indirect upward pressure on Part B premiums. CMS said it will continue using AI-based surveillance tools to flag unusual billing activity as it emerges.

In plain words

Medicare's main agency stopped 1.6 billion dollars in bad laboratory payments using computer tools that look for unusual billing. The money was saved or recovered four different ways. First, 157 fake lab companies were kicked out of Medicare, stopping 732 million dollars. Second, payments to 185 suspicious labs were frozen, saving more than 500 million dollars. Third, 276 million dollars was taken back after 442 overbillings were found. Fourth, 127 million dollars was blocked after tips were shared with law enforcement.

In one case, a Texas lab started billing and was caught within weeks. The agency froze its payments and then removed it from Medicare.

Lab fraud matters to Medicare users because it pushes up overall program costs over time, which can affect what Part B charges in future years.

Source: CMS
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

CMS Completes January 2027 Diagnosis Code Updates to Medicare Coverage Policies

Part 2 of 2 of the January 2027 ICD-10 coding revisions to National Coverage Determinations is now published, finishing the update cycle that defines which patient diagnoses qualify for covered services.

August 27, 2026

Policy & oversight

CMS Tells Dermatologists to Document Same-Day Visits Carefully Before Billing Them Separately From Procedures

A compliance notice in the August 27 MLN Connects newsletter reminds skin care providers that Medicare's global surgery rules bundle most same-day evaluation and management services into the procedure payment unless strict documentation standards are met.

August 27, 2026

Policy & oversight

Alabama Distributes 144 Million Dollars in Federal Rural Health Grants to 138 Organizations Statewide

The first round of awards from Alabama's CMS-funded Rural Health Transformation Program targets mental health, maternal care, emergency services, and healthcare workforce gaps across all 67 counties.

August 27, 2026

Policy & oversight

Three States Audited by Federal Watchdog Failed to Ensure Mental Health Parity Rules Were Followed in Medicaid Plans

OIG found Kansas, New York, and Arizona did not ensure their Medicaid managed care plans applied the same prior authorization standards to mental health and addiction care as to physical health services, a compliance failure the watchdog has now documented in nearly every state it has reviewed.

August 26, 2026

Policy & oversight

CMS Proposes Cutting What Medicare Pays for Discounted Hospital Drugs by 37 Percent, With Safety-Net Hospitals Projected to Absorb the Biggest Losses

A proposed 2027 Medicare hospital outpatient rule would sharply lower reimbursement for drugs purchased through the 340B discount program, redirecting an estimated 4.85 billion dollars away from drug payments toward other outpatient services, with the impact falling unevenly across hospital types.

August 25, 2026

Policy & oversight

CMS Proposes That Medicare's Home Health Benefit May Now Cover Skilled Palliative Care Services

A proposed rule published July 6, 2026 would clarify that Medicare can pay home health agencies for skilled palliative care visits for seriously ill homebound patients, without requiring those patients to give up treatment. Comments close August 31.

August 24, 2026